Abstract
Little is known mechanistically about why implanted glucose sensors lag behind blood glucose levels in both the time to peak sensor response and the magnitude of peak sensor response. A mathematical model of glucose transport from capillaries through surrounding tissue to the sensor surface was constructed to address how different aspects of the tissue affect glucose transport to an implanted sensor. Physiologically relevant values of capsule diffusion coefficient, capsule porosity, cellular glucose consumption, capsule thickness, and subcutaneous vessel density were used as inputs to create simulated sensor traces that mimic experimental instances of time lag and concentration attenuation relative to a given blood glucose profile. Using logarithmic sensitivity analysis, each parameter was analyzed to study the effect of these variables on both lag and attenuation. Results identify capsule thickness as the strongest determinant of sensor time lag, while subcutaneous vessel density and capsule porosity had the largest effects on attenuation of glucose that reaches the sensor surface. These findings provide mechanistic insight for the rational design of sensor modifications that may alleviate the deleterious consequences of tissue effects on implanted sensor performance.
Similar content being viewed by others
References
National Diabetes Fact Sheet, 2007. Department of Health and Human Services 2007
Bloomgarden ZT (2002) Treatment issues in type 1 diabetes. Diab Care 25(1):230–238
Garg SK (2009) The future of continuous glucose monitoring. Diabetes Technol Ther 11(Suppl 1):S1–S3
Skyler JS (2009) Continuous glucose monitoring: an overview of its development. Diabetes Technol Ther 11(Suppl 1):S5–S10
Wisniewski N, Klitzman B, Miller B, Reichert WM (2001) Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res 57(4):513–521
Wilson GS, Gifford R (2005) Biosensors for real-time in vivo measurements. Biosens Bioelectron 20(12):2388–2403
Reichert WM, Sharkawy AA (1999) Active implants: biosensors. handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials. Taylor and Francis, Philadelphia, pp 439–460
Frost MC, Meyerhoff ME (2002) Implantable chemical sensors for real-time clinical monitoring: progress and challenges. Curr Opin Chem Biol 6(5):633–641
Clark H, Barbari TA, Stump K, Rao G (2000) Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. J Biomed Mater Res 52(1):183–192
Dungel P, Long N, Yu B, Moussy Y, Moussy F (2007) Study of the effects of tissue reactions on the function of implanted glucose sensors. J Biomed Mater Res 85A(3):699–706
Anderson JM (2001) Biological responses to materials. Annu Rev Mater Sci 31(1):81
Yu B, Ju Y, West L, Moussy Y, Moussy F (2007) An investigation of long-term performance of minimally invasive glucose biosensors. Diab Technol Ther 9(3):265–275
Koschwanez HE, Yap FY, Klitzman B, Reichert WM (2008) In vitro and in vivo characterization of porous poly-l-lactic acid coatings for subcutaneously implanted glucose sensors. J Biomed Mater Res 87A(3):792–807
Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NAJM, Nolte RJM et al (2001) Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res 54(1):69–75
Wisniewski N, Moussy F, Reichert WM (2000) Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 366(6–7):611–621
Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM (2007) Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A 81(4):858–869
Patil SD, Papadmitrakopoulos F, Burgess DJ (2007) Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 117(1):68–79
Clark HR, Barbari TA, Rao G (1999) Modeling the response time of an in vivo glucose affinity sensor. Biotechnol Prog 15(2):259–266
Sharkawy AA, Klitzman B, Truskey GA, Reichert WM (1997) Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 37(3):401–412
Yuan F (1998) Transvascular drug delivery in solid tumors. Semin Radiat Oncol 8(3):164–175
Ahmed N, Kansara M, Berridge MV (1997) Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J 327:369–375
Ciaraldi TP, Kolterma OG, Siegel JA, Olefsky JM (1979) Insulin-stimulated glucose transport in human adipocytes. Am J Physiol Gastrointest Liver Physiol 236(6):621–625
Koschwanez HE. The effect of porous poly-l-lactic acid coatings on tissue response and subsequent glucose sensor performance [PhD Dissertation]. Durham, NC USA: Duke University; 2009.
Armour JC, Lucisano JY, McKean BD, Gough DA (1990) Application of chronic intravascular blood glucose sensor in dogs. Diabetes 39(12):1519–1526
Kholodenko BN, Hoek JB, Westerhoff HV, Brown GC (1997) Quantification of information transfer via cellular signal transduction pathways. FEBS Lett 419(2):430–434
Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D (1994) Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. ASAIO J 40(2):157–163
Sieminski AL, Gooch KJ (2000) Biomaterial-microvasculature interactions. Biomaterials 21(22):2233–2241
Sharkawy AA, Klitzman B, Truskey GA, Reichert WM (1998) Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 40(4):598–605
Ward WK, Wood MD, Troupe JE (2000) Understanding spontaneous output fluctuations of an amperometric glucose sensor: effect of inhalation anesthesia and use of a nonenzyme containing electrode. ASAIO J 46(5):540–546
Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, Gross JF (1989) Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 17(1):91–99
Acknowledgments
This work was supported by an NIH Biotechnology Predoctoral Fellowship, T32 GM 8555 (MTN) and NIH Grant DK 54932 (WMR). The authors thank Mr. Robert D. Kirkton, Dr. Nima Badie, and Dr. Charles S. Wallace for valuable feedback on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Novak, M.T., Yuan, F. & Reichert, W.M. Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation. Anal Bioanal Chem 398, 1695–1705 (2010). https://doi.org/10.1007/s00216-010-4097-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-4097-6